What is Agelessrx?
AgelessRx is dedicated to providing science-backed longevity treatments aimed at improving healthspan and overall wellness. The company offers a range of products, including Metformin and NAD+, to address diverse health needs such as weight management, cardiovascular health, and cognitive function. By prioritizing research and adhering to expert medical protocols, AgelessRx strives to make the science of longevity accessible and effective. Their commitment extends to ensuring prompt delivery and continuous client support, empowering individuals to proactively manage their health.
How much funding has Agelessrx raised?
Agelessrx has raised a total of $5.5M across 1 funding round:
Private Equity
$5.5M
Private Equity (2026): $5.5M, investors not publicly disclosed
What's next for Agelessrx?
The substantial enterprise-level funding and recent strategic investment position Agelessrx for accelerated growth and expanded market reach. This capital infusion is expected to fuel further research and development into novel longevity therapies, enhance operational capabilities, and potentially broaden their service offerings. The company's focus on making longevity science accessible suggests a strategic direction towards scaling its platform and solidifying its presence in the rapidly evolving health and wellness sector.
See full Agelessrx company page
